We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

AMRI Completes OsoBio Acquisition

News   Jul 01, 2014

 
AMRI Completes OsoBio Acquisition
 
 
 

RELATED ARTICLES

Technology Senses How Parkinson's Patients Respond to Medication

News

Researchers have developed an innovative way to automatically and reliably detect and monitor medication "on" and "off" states in Parkinson's disease patients.

READ MORE

Synthetic Peptide Inhibits Toxicity and Aggregation of Protein in Alzheimer's Disease

News

Alzheimer’s is a disease of aggregation. Neurons in the human brain make a protein called amyloid beta. Now, a team led by researchers at the University of Washington has developed synthetic peptides that target and inhibit those small, toxic aggregates.

READ MORE

A New Way to Build Novel Synthetic Biomolecules

News

Army scientists have discovered how to build novel synthetic biomolecule complexes that they believe are a critical step towards biotemplated advanced materials.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE